Effect of treatment with calcium antagonists in vitro and in vivo on the contractile response of isolated rat and human detrusor muscle

被引:16
作者
Elliott, RA
Norman, RI
Parker, SG
Whitaker, RP
Castleden, CM
机构
[1] LEICESTER ROYAL INFIRM,DEPT PATHOL,TOXICOL LAB,LEICESTER LE2 7LX,LEICS,ENGLAND
[2] UNIV LEICESTER,LEICESTER ROYAL INFIRM,DEPT MED & THERAPEUT,LEICESTER,LEICS,ENGLAND
关键词
calcium antagonist; human; rat; urinary bladder;
D O I
10.1042/cs0910467
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. The effect of calcium antagonists on the contractile response of human and rat isolated detrusor muscle in vitro was investigated, The effect of treatment with nimodipine on rat detrusor muscle in vivo was also examined. 2. Nimodipine 0.1 mu mol/l, nifedipine 0.1 mu mol/l, nifedipine 0.25 mu mol/l and verapamil 1.5 mu mol/l reduced the maximum contractile response of isolated human detrusor muscle to carbachol by 42%, 35%, 41% and 28% respectively (P < 0.01). Verapamil 0.1 mu mol/l had no significant effect on contractile response. 3. Nimodipine 0.1 mu mol/l reduced the maximum contractile response of isolated rat detrusor muscle in vitro to electrical field stimulation and carbachol by 53% and 84% respectively (P < 0.01). 4. Rats were pretreated with nimodipine for 8 days (5 mg day(-1) kg(-1)) or with a single dose, Serum nimodipine concentrations were higher in rats treated for 8 days, In rats treated with nimodipine for 8 days there was no significant difference in detrusor contractile response compared with controls. However, after one dose of nimodipine the maximum contractile response was significantly reduced compared with controls (P < 0.05). 5. At the concentrations studied, nimodipine had a greater inhibitory effect on the contractile response of isolated human detrusor muscle, Nimodipine significantly reduced the contractile response of rat detrusor muscle in vitro and after a single dose in vivo, but had no significant effect after 8 days' treatment in vivo, It is possible that chronic oral treatment with nimodipine caused an up-regulation of 1,4-dihydropyridine-sensitive calcium channels, which may explain the lack of clinical effect of chronic treatment with calcium antagonists in patients with detrusor instability.
引用
收藏
页码:467 / 474
页数:8
相关论文
共 26 条
[1]   TACHYPHYLAXIS TO VERAPAMIL [J].
ADERKA, D ;
LEVY, A ;
PINKHAS, J .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (01) :207-207
[2]   INVIVO EFFECTS OF DIFFERENT ANTISPASMODIC DRUGS ON THE RAT BLADDER CONTRACTIONS INDUCED BY TOPICALLY APPLIED KCL [J].
ANGELICO, P ;
GUARNERI, L ;
FREDELLA, B ;
TESTA, R .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1992, 27 (01) :33-39
[3]   DIFFERENTIAL SUSCEPTIBILITY OF CHOLINERGIC AND NONCHOLINERGIC NEUROGENIC RESPONSES TO CALCIUM-CHANNEL BLOCKERS AND LOW CA-2+ MEDIUM IN RAT URINARY-BLADDER [J].
BHAT, MB ;
MISHRA, SK ;
RAVIPRAKASH, V .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (04) :837-842
[4]   THE EFFECTS OF BAY K-8644 AND NIFEDIPINE ON THE RESPONSES OF RAT URINARY-BLADDER TO ELECTRICAL-FIELD STIMULATION, BETA,GAMMA-METHYLENE ATP AND ACETYLCHOLINE [J].
BO, X ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (02) :494-498
[5]   MECHANISMS OF ACTION OF TRANSMITTERS AND OTHER SUBSTANCES ON SMOOTH-MUSCLE [J].
BOLTON, TB .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :606-718
[6]   COMPARISON OF BAY K-8644, NITRENDIPINE AND ATROPINE ON SPONTANEOUS AND PELVIC-NERVE-INDUCED BLADDER CONTRACTIONS ON RAT BLADDER INVIVO [J].
DIEDERICHS, W ;
SROKA, J ;
GRAFF, J .
UROLOGICAL RESEARCH, 1992, 20 (01) :49-53
[7]   THE DIRECT EFFECTS OF DIETHYLSTILBESTROL AND NIFEDIPINE ON THE CONTRACTILE RESPONSES OF ISOLATED HUMAN AND RAT DETRUSOR MUSCLES [J].
ELLIOTT, RA ;
CASTLEDEN, CM ;
MIODRAG, A ;
KIRWAN, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) :149-155
[8]  
FAUSTINI S, 1989, ARZNEIMITTEL-FORSCH, V39-2, P899
[9]   NIFEDIPINE PHARMACOKINETICS DURING PRETERM LABOR TOCOLYSIS [J].
FERGUSON, JE ;
SCHUTZ, T ;
PERSHE, R ;
STEVENSON, DK ;
BLASCHKE, T .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) :1485-1490
[10]  
FERRANTE J, 1990, PHARMACOL REV, V42, P29